INTRODUCTION
Electromyography (EMG) is defined as the study of the muscle electrical activity for diagnosis and look out results after treatment. It could be divided in invasive and no invasive, the first is when an electrode is placed in the skin over the muscle, and invasive is when a mono polar needle with politetrafluoroetilene cover is introduced in the muscle to be studied. The bioelectrical potentials to be studied are amplified and showed in a cathode ray oscilloscope to complete the visual analysis in a screen 1 .
The postparalytic hemifacial spasm presents when the muscles innervated by the facial undergo an aberrant regeneration, generating epiphora and synchronous contraction. This spastic action could be very brief or persist as tonic contraction of several seconds. Differential diagnosis includes blepharospasm, facial myokimiasis, Meige syndrome and focal crisis 2 .
Electromyographically is described as fascicular potentials of the motor unit secondary to the spontaneous activation of individual motor muscle fibers. It could be observed in patients with partial and chronic denervation, secondary to neuromuscular diseases or sequelae of facial paralisis 3 .
CASE REPORT
A female patient of 57 years-old came to consult with a diagnosis of postparalytic hemifacial spasm of 10 years of evolution. She denies pathological background.
At physical exam she presented postparalytic hemifacial spasm in right superciliary, nasogenian and chin region.
Initial electromyography showed a right facial nerve neuropathy with axonal degeneration grade III of House-Beckmann, a Botman and Jongkess moderated and Smith II paresis, with limitation of movements in frontal, orbicular and lip depressor muscles, with right temporal, zygomatic, buccal and marginal mandibular branches ( Figure 1 ).
Figure1. A) Positioning the base electrode B) Positive Bipolar electrode y C) Negative electrode in the frontal muscle surface

Figure2. Facial region map for the position of electrodes during electromyography
Electromyography signals detected in the left face muscles at rest (healthy side) were of 5 mV with a frequency of 10 Hz, but in the right face muscles (affected side) signals have a higher frequency of 40 Hz, with increased spontaneous activity of motor units by the involuntary contraction of muscular fibers every 3 to 5 milliseconds (Fig 2) . The conclusion of this study was a higher involuntary contraction force (vertical wave amplitude) in the lips depressor and frontal muscles, a higher frequency between spasm in the orbicularis muscle eyelids and lips, and lasting contraction in the upper lip lift muscle ( Figure 3, 4 y 5 During follow up at 15 daysthe control electromyography reports a fewer presence of involuntary movements in the affected muscles with an amplitude of 15Hz. The frequency improves significantly with a segment between spasm of more than 3 minutes. Although some abnormal characteristics in the driving unit were observed, the excitability of the muscle membrane improves, showing wide segments in the baseline.
Figure4. A) Initial electromyography of the lip orbicular muscle B) Control electromyography 15 days after application of botulin toxin.in the lip orbicular muscle
Figure5. A) Initial electromyography of the lip depressor muscle B) Control electromyography 15 days after application of botulin toxin in the lip depressor muscle
DISCUSSION
According to Jinnah, the hemifacial spasm in an involuntary contraction of the expression muscles, with a spontaneous, intermittent or persistent beginning, and variable force and intensity 4 .
The ophthalmologic and neurologic exams are essential to stablish a diagnosis of essential benign spasm or secondary to systemic diseases like in Parkinson disease 5 .
The post paralytic hemifacial spasm is secondary to an aberrant regeneration of new axons of the facial nerve to the facial muscle fibers.
This aberrant innervation produces a nonintentional movement in another area of the face. For example, when smiling the involuntary eyelid closure may be present 6 .
The peripheralneurectomy of facial nerve is considered the more efficient treatment, other mentioned treatments are the alcohol infiltration to produce a chemical necrosis, percutaneous thermolysis or selective avulsion of facial nerve, with the severe secondary adverse effects 7, 8 . Brin and Cols. mention a series of cases for the treatment of hemifacial spasm by the infiltration of botulin toxin, describing an improvement in 93.1% of periocular and perioral spasms, with an effect for 17.4 weeks 9, 10 . The actual treatment for hemifacial spasm includes an electromyography to measure the motor unit activation and the electric variation after infiltration of botulin toxin.
Botulinum toxin type A was introduced by Dr. Allen Scott in the late 60`s, being a derived obtained from Clostridium botulinum. The action mechanism is the blockade of acetylcholine release from the presynaptic motor nerve unit. 4 The contraindications for application of Botulin toxin are rare because is a drug classified as C category and their use is contraindicated during pregnancy, breastfeeding and neuromuscular diseases as myasthenia gravis, Eaton-Lambert syndrome and lateral amyotrophic sclerosis. This drug must be administered carefully in patients with consume of aminoglycosides, tetracycline, polymyxins, penicillin, anticholinesterases, and calcium channel blockers, because this may alter the conduction in the neuromuscular union 4, 5, 9 .
According to other studies, the electromyography is very useful to identify the correct place and dose of botulin toxin administered, allowing us to control and follow up the involuntary muscular activity in a practical and safe way 8, [10] [11] [12] .
CONCLUSIONS
The therapeutic results depend on the correct diagnosis, an electromyography test to select the affected muscles and allow a correct infiltration of the precise doses to obtain an effective treatment. The empiric application of botulin toxin in facial and cervical muscles must be avoided, we suggest to guide the treatment with the electromyography registry to control the precise doses and obtain the better results.
The latency for type a botulin toxin is one week and it last 4 to 8 weeks, with a limit for administration of 1 dose each 12 weeks to avoid develop of antibodies against the toxin.
